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ABSTRACT
Background: We  report the case of a 77-year-old
female with acquired angioneurotic edema, C1 esterase
inhibitor level = 4mg/dL, who was scheduled to undergo
a laparoscopic splenectomy.
Methods: In the operating room, we administered on
call 500 units (UI) of C1 esterase inhibitor concentrate
intravenously.  Intraoperative hemodynamic instability
and generalized blood oozing improved following the
administration of aprotinin 250 000 UI intravenous (IV)
drip.
Conclusion: We  recommend the administration of an
antifibrinolytic agent in addition to C1 esterase inhibitor
concentrate in patients with acquired angioneurotic
edema.
Key Words: Laparoscopic splenectomy, Acquired
angioneurotic edema, Aprotinin.
INTRODUCTION
Angioneurotic edema is a demarcated painless, nonpru-
ritic, nonpitting edema of the deep dermis and subcuta-
neous tissue.  It usually involves the face, upper airway,
gastro-intestinal tract and extremities.1 Osler2 in 1888
demonstrated the hereditary nature of the disease.  In the
early 1960s, hereditary angioneurotic edema (HAE) was
shown to be caused by deficiency of C1 esterase
inhibitor, also called C1 inhibitor (C1INH).3,4 In 1972, an
acquired form of C1INH deficiency (AAE) was first
reported.5
We report the case of a woman with acquired angioneu-
rotic edema who underwent laparoscopic splenectomy
and experienced intraoperative hemodynamic instability
and bleeding in the immediate postoperative period.
CASE REPORT
A 77-year-old female who weighed 60 kg and had
splenomegaly associated with anemia and neutropenia
was scheduled to undergo a laparoscopic splenectomy.
Two years prior to the present admission, she had an
episode of upper airway edema following a tooth extrac-
tion.  She also suffered from recurrent episodes of
abdominal pain and swelling of the upper extremities
and the face, which was diagnosed as angioneurotic
edema.  The diagnosis was confirmed by a low level of
C1 esterase inhibitor (C1INH) of 4 mg/dL (normal =11-26
mg/dL).
On the morning of the scheduled laparoscopy, 500 units
(UI) of C1INH concentrate was given intravenously on
call in the operating room.  The patient was premedicat-
ed with glycopyrrolate 0.2 mg intramuscular (IM) and
diazepam 5 mg per os.  Anesthesia was induced with
propofol 2 mg/kg, vecuronium 0.1 mg/kg, fentanyl 2
mg/kg, and midazolam 1 mg, and was maintained with
isoflurane 1% in nitrous oxide:oxygen (2:1).  The patient
was stable during the first hour of surgery; her systolic
blood pressure varied between 110-115 mm Hg, and her
heart rate varied between 50-60 beats/min.  Suddenly,
her heart rate dropped to 30 beats/min, and her systolic
blood pressure dropped to 30 mm Hg.  Two units of
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packed red blood cells and two units of Hemaccel were
rapidly infused.  Also, multiple doses of ephedrine (a
total of 30 mg) and phenylephrine (a total of 100 mg)
were administered.  The blood pressure was only raised
to 60/20 mm Hg.  Epinephrine 0.2 mg was then adminis-
tered as a bolus, which increased the blood pressure to
90 mm Hg.  Epinephrine drip was then started and titrat-
ed according to the blood pressure.  Also, the patient
received an additional dose of C1INH concentrate (1000
UI), two units of blood, and two units of fresh frozen
plasma.  The spleen was completely mobilized, placed in
a bag, and brought out through the umbilical trocar.  The
incision was widened so that the spleen could be
removed.  The size of the spleen was 27 x 13 x 7 cm.  At
the end of the procedure, neuromuscular blockade was
reversed with a mixture of neostigmine 0.05 mg/kg and
glycopyrrolate 0.01 mg/kg, and the trachea was extubat-
ed.
In the recovery room, extensive bleeding from the
abdominal drain was observed.  Exploratory laparotomy
did not reveal any surgical bleeding, but generalized ooz-
ing from the raw surface was discovered.  Aprotinin 250
000 UI was administered as an IV drip for 30 minutes and
was followed by a significant decrease in bleeding.  The
epinephrine drip was decreased progressively and was
stopped at the end of surgery.  The trachea was extubat-
ed during the evening of the surgery, and the patient was
discharged 3 days later.
DISCUSSION
HAE is caused by a defective C1INH gene that produces
either no C1 esterase inhibitor (type I) or dysfunctional
C1INH (type II), which is measurable for antigen but is
inactive.6 C1INH inhibits the first component of activat-
ed complement.  In addition, it inhibits the clot-promot-
ing and kinin-releasing plasma enzymes, including acti-
vated Hageman factor (factor XIIa), factor XIa, plasma
kallikrein, and the fibrinolytic enzyme plasmin.7,8 Also, it
may be a secondary inhibitor of tissue plasminogen acti-
vator.9
Acquired C1INH deficiency is caused by the consumption
of C1NH or by autoantibodies directed against C1INH.
Also, two types of acquired C1INH deficiency have been
identified.  Type I is induced by malignancy that activates
complement or produces idiotype anti-idiotypes or other
immune complexes.  In contrast, type II is not associated
with underlying disorders, except for the presence of an
autoantibody that interferes with C1INH activity.10
Our patient has a case of acquired type I C1INH defi-
ciency as evidenced by the onset of the angioneurotic
edema at an old age, absence of a positive family histo-
ry, and the association with a lymphoproliferative dis-
ease.11 The pathology of the excised spleen of the
patient manifested non-Hodgkin’s lymphoma.
Two events were striking in this case:  the intraoperative
hemodynamic instability and the postoperative bleeding.
These events may be attributed to the activation of the
contact phase (factor XII, prekallikrein and high molecu-
lar weight kininogen) by surgery12 and to fibrinolysis.
Patients with AAE display signs of activation of the con-
tact phase and the fibrinolysis during basal conditions as
well as during attacks.  Such activation cannot be
explained by a deficiency of C1INH alone, which does
not activate the contact phase or fibrinolysis as shown in
patients with HAE.  Therefore, in addition to C1INH defi-
ciency, some other mechanism for C1 depletion and con-
tact activation must be acting in patients with AAE.13
This may explain why the infusion of C1 inhibitor con-
centrate in our patient did not prevent the intraoperative
hemodynamic instability and the postoperative bleeding.
Cicardi et al14 described the high effectiveness of the
antifibrinolytic agent tranexamic acid (trans-4-
aminoethylcyclohexane-1-carboxylic acid) [AMCA] for
prophylaxis in patients with AAE.  The effectiveness of
AMCA in AAE is significantly greater than that reported
for patients with HAE.  The mechanism of action of
AMCA in AAE patients probably depends on its antiplas-
min activity that impairs the release of vasoactive media-
tors.13,15 In our patient, the infusion of aprotinin 250 000
UI was highly effective in providing hemodynamic sta-
bility and controlling the raw surface oozing, probably
through its antiplasmin and its antikallikrein effects that
inhibit the contact phase of coagulation.16
In conclusion, we present a case of AAE in a patient
undergoing laparoscopic splenectomy.  The diagnosis of
AAE was evidenced by a low level of C1 inhibitor, the
onset at old age, absence of a positive family history, and
the association with non-Hodgkin’s lymphoma as mani-
fested by the pathology of the spleen.  The patient was
treated prophylactically with C1INH concentrate.
Intraoperative hemodynamic instability and postopera-
tive bleeding were controlled successfully with aprotinin.
The effectiveness of aprotinin is probably due to its
antikallikrein and its antiplasmin effects.  We recommend
that patients with AAE undergoing elective surgery
receive an antifibrinolytic agent in addition to C1INH
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